Please assess the completion status of the following clinical trial:

Trial Title: FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject must be willing to give written informed consent~* Probands 18 years of age or greater~* Both eyes will be assessed in the study~Exclusion Criteria:~* Opacities of ocular media excluding detailed observation of the retina~* Gastrointestinal diseases that could cause disturbance of dietary absorption~* History of lutein supplementation~* Allergy to lutein and zeaxanthin~* Missing compliance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- AMD (Type: EXPERIMENTAL): None
- healthy control (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).